A dual glucagon/GLP-1 receptor agonist designed for superior metabolic effects. By simultaneously activating both glucagon and GLP-1 pathways, it enhances energy expenditure, promotes significant lipolysis and fat oxidation, suppresses appetite, and improves glycemic control while helping preserve lean muscle mass during weight loss. It represents a next-generation approach to obesity and metabolic optimization.
